| Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients (NCT07771400) | Latin American Cooperative Oncology Group | 2026-09-01 |
| Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America (NCT07192991) | Latin American Cooperative Oncology Group | 2025-11-03 |
| A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer) (NCT06822543) | Latin American Cooperative Oncology Group | 2025-09-12 |
| Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer (NCT06527690) | Latin American Cooperative Oncology Group | 2025-04-30 |
| Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort (NCT06279442) | Latin American Cooperative Oncology Group | 2024-10-09 |
| Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade (NCT06068985) | Latin American Cooperative Oncology Group | 2024-09-05 |
| Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil (NCT06014580) | Latin American Cooperative Oncology Group | 2023-11-27 |
| Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study (NCT05776147) | Latin American Cooperative Oncology Group | 2023-11-09 |
| Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America (NCT05924789) | Latin American Cooperative Oncology Group | 2023-08-11 |
| A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America (NCT05857397) | Latin American Cooperative Oncology Group | 2023-07-21 |
| A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection (NCT05328765) | Latin American Cooperative Oncology Group | 2023-06-09 |
| Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations (NCT05299125) | Latin American Cooperative Oncology Group | 2023-05-24 |
| Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American (NCT05184504) | Latin American Cooperative Oncology Group | 2022-09-01 |
| Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil (NCT05169372) | Latin American Cooperative Oncology Group | 2022-05-11 |
| Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers (NCT04943445) | Latin American Cooperative Oncology Group | 2022-02-22 |
| Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil (NCT05034393) | Latin American Cooperative Oncology Group | 2022-02-04 |
| Molecular Characterization of Penile Cancers in Developing Countries (NCT06068998) | Latin American Cooperative Oncology Group | 2021-12-17 |
| Epidemiological Landscape of Cervical Cancer in Latin America (NCT04947605) | Latin American Cooperative Oncology Group | 2021-11-04 |
| Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil (NCT04948411) | Latin American Cooperative Oncology Group | 2021-09-30 |
| Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers (NCT04230408) | Latin American Cooperative Oncology Group | 2021-03-05 |
| Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy (NCT04579133) | Latin American Cooperative Oncology Group | 2021-03-01 |
| Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer (NCT04540692) | Latin American Cooperative Oncology Group | 2021-01-12 |
| HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (NCT04575558) | Latin American Cooperative Oncology Group | 2020-06-30 |
| Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer (NCT04224740) | Latin American Cooperative Oncology Group | 2020-06-15 |
| Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors (NCT05168631) | Latin American Cooperative Oncology Group | 2020-05-16 |
| Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil (NCT04947683) | Latin American Cooperative Oncology Group | 2020-04-06 |
| Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer (NCT03936270) | Latin American Cooperative Oncology Group | 2020-03-05 |
| Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions. (NCT04962919) | Latin American Cooperative Oncology Group | 2020-01-14 |
| Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil (NCT03836469) | Latin American Cooperative Oncology Group | 2019-09-25 |
| Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America (NCT03942497) | Latin American Cooperative Oncology Group | 2019-08-01 |
| Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America (NCT04227457) | Latin American Cooperative Oncology Group | 2018-07-25 |
| Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels (NCT02867020) | Latin American Cooperative Oncology Group | 2017-10-11 |